جستجوی پیشرفته

پاک کن

فیلترهای فعلی

پالایش جستجو:

جهت پالایش جستجو از فیلترها استفاده نمایید .


رکورد(های) بازیابی شده :
PreviewIssue DateTitleContributor(s)
2018 DAD Volume 185 April (58).pdf.jpg2018Corrigendum to: “Does outcome measurement of treatment for substance use disorder reflect the personal concerns of patients? A scoping review of measures recommended in Europe” [Drug Alcohol Dependence 179 (2017) 299–308] (S0376871617303691) (10.1016/j.drAlves, Paula; Sales, Celia; Ashworth, Mark
2018 Epidemiology Volume 29 Issue 3 May (7).pdf.jpg2018Implementation of instrumental variable bounds for data missing not at randomMarden, Jessica R.; Wang, Linbo; Tchetgen Tchetgen, Eric J.; Walter, Stefan; Glymour, M. Maria; Wirth, Kathleen E.
2018 Epidemiology Volume 29 Issue 3 May (15).pdf.jpg2018Incidence and risk factors for prediabetes and diabetes mellitus among HIV infected adults on antiretroviral therapyNansseu, Jobert Richie; Bigna, Jean Joel; Kaze, Arnaud D.; Noubiap, Jean Jacques
2018 DDIP Volume 44 Issue 5 May (9).pdf.jpg2018Development of stabilized tenofovir disoproxil tablet : degradation profile , stabilization , and bioequivalence in beagle dogsOh, Ga-hui; Kim, Joo-eun; Park, Young-joon
2018 DAD Volume 185 April (59).pdf.jpg2018Alcohol mixed with energy drinks and arrhythmiasMattioli, Anna Vittoria; Manenti, Antonio; Farinetti, Alberto
2018 DDIP Volume 44 Issue 5 May (19).pdf.jpg2018Selected abstracts from Excipient Fest 2017 Selected abstracts from Excipient Fest 2017Development, Drug; Pharmacy, Industrial
2018 EAD Volume 32 Issue 3 March (27).pdf.jpg2018Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT studyKörber, a.; Thaçi, D.; von Kiedrowski, R.; Bachhuber, T.; Melzer, N.; Kasparek, T.; Kraehn-Senftleben, G.; Amon, U.; Augustin, M.
2018 EAD Volume 32 Issue 3 March (41).pdf.jpg2018Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE studyReich, K.; Gooderham, M.; Bewley, a.; Green, L.; Soung, J.; Petric, R.; Marcsisin, J.; Cirulli, J.; Chen, R.; Piguet, V.
2018 EAD Volume 32 Issue 4 April (31).pdf.jpg2018Rosacea and subsequent diagnosis for Parkinson's disease: A large, urban, single center, US patient population retrospective studyMathieu, R.J.; Guido, N.; Ibler, E.; Serrano, L.; Rangel, S.M.; Schlosser, B.J.; West, D.P.; Laumann, a.E.; Nardone, B.
2018 EAD Volume 32 Issue 3 March (31).pdf.jpg2018Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989–2009van der Leest, R. J.T.; Hollestein, L. M.; Liu, L.; Nijsten, T.; de Vries, E.